# A Study of ARRY-371797 in Subjects Undergoing Third Molar Extraction

> **NCT00542035** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 103 (actual)

## Conditions studied

- Dental Pain

## Interventions

- **DRUG:** ARRY-371797, p38 inhibitor; oral
- **DRUG:** Placebo; oral
- **DRUG:** Placebo; oral
- **DRUG:** ARRY-371797, p38 inhibitor; oral

## Key facts

- **NCT ID:** NCT00542035
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11-11
- **Primary completion:** 2008-02-11
- **Final completion:** 2008-02-11
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2021-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00542035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00542035, "A Study of ARRY-371797 in Subjects Undergoing Third Molar Extraction". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00542035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*